These facts are updated till 23 Jan 2024, and are based on Volza's Export Import data India Export data of HSN Code 30049049, sourced from 70 countries export import shipments with names of buyers, suppliers, top decision maker's contact information like phone, email and LinkedIn profiles.
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
30049049 | INJECTION >> TRIOXIDE INJECTION ARSITRI ARSENIC TRIOXIDE INJECTION 10MG-10ML B.NO:113206 MANUFACTURING .DT:02-2019; EXP.DT.01-2021 ; 10MG -10ML B.NO:113206 ; EXP.DT .01-2021 | India | Algeria | 403 | |||
30049049 | MEDICAMENTS >> MEDICAMENTS EXCLUDING *" MEDICAMENTSEXCLUDING GOODS OF HEADING 3002,3005 OR 3006 CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSESINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS OR IN FORMS OR PACKINGS FOR | India | Algeria | 1 | |||
30049049 | TABS >> TABS IMATINIB IMALEK 400 TABS IMATINIB MESYLATE TABLE | India | Algeria | 3276 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE ALPHA FORM 400MG PACK SIZE3X10S ; MESYLATE ALPHA | India | Algeria | 2745 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMALEK 100MG TABLETS IMATINIB MESYLATE | India | Algeria | 18519 | 60 More Columns Available | ||
30049049 | TABLETS >> MESYLATE TABLETS IMALEK 400 TABS IMATINIB MESYLATE TABLETS 400 MG PACK: 6S STRIP OTHER EACH FILM-COATED TABS CONTNS: IMATINIB MESY ; TABLE TS ; EAC H | India | Algeria | 4739 | |||
30049049 | MEDICAMENTS >> MEDICAMENTS EXCLUDING *" MEDICAMENTSEXCLUDING GOODS OF HEADING 3002,3005 OR 3006 CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSESINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS OR IN FORMS OR PACKINGS FOR | India | Algeria | 1 | |||
30049049 | DOCUMENT >> TAX DOCUMENT NO1301403031 DT16.08.2019 " AP PLIED ONLINE FOR LUT - ARN - AD270319006 825X "DT 22-03-2019 VALID UPTO DT31.0 | India | Algeria | 0.00 | |||
30049049 | DOCUMENT >> TAX DOCUMENT NO: 1301402369 DT: 27.06.2019 APPLIED ONLINE FOR LUT ARN NO.AD270319006825X VALID UPTO.31.03.2020 ; 27.06.2019 APPLIED ; NO.AD2703190 06825X | India | Algeria | 0.00 | |||
30049049 | TABLETS >> TABLETS CAPECIINE CAPEGARD 500MG TABLETS CAPECIINE 500MGTABLETS 1X10'S-PACK ; 500MG TABLETS | India | Algeria | 179960 | |||
30049049 | " APPLIED ONLINE FOR LUT - ARN - AD27032 | India | Algeria | 0.00 | |||
30049049 | TABLETS >> TABLETS CAPECITABINE CAPEGARD 500 TABLETS CAPECITABINE 500MG 1 X 10S-NOS ; 500MG | India | Algeria | 130460 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE | India | Algeria | 3600 | |||
30049049 | TIME >> I-WE UNDERTAKE TO ABIDE BY PROVISIONS OFFOREIGN EXCHANGE MANAGEMENT ACT 1999 AS AMENDED FROM TIME TO TIME INCLUDING ; OF FOREIGN | India | Algeria | 0.00 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE | India | Algeria | 37350 | |||
30049049 | MEDICAMENTS >> MEDICAMENTS EXCLUDING " MEDICAMENTSEXCLUDING GOODS OF HEADING 3002,3005 OR 3006 CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSESINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS OR IN FORMS OR PACKINGS FOR | India | Algeria | 0.00 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE ALPHA FORM 400MG 1200 PACK X3X10S=36000 NOS ; MESYLATE ALPHA ; X3X10S=3 6000 | India | Algeria | 36000 | |||
30049049 | FREE >> FREE SAMPLE FREE SAMPLE OF NCV: HODPRO PROCARBAZINE | India | Algeria | 100 | |||
30049049 | CAPS >> HYDROCHLORIDE CAPS HODPRO PROCARBAZINE HYDROCHLORIDE CAPS U | India | Algeria | 12400 | |||
30049049 | APPLIED ONLINE FOR LUT ARN AD27032001168 | India | Algeria | 0.01 | |||
30049049 | CAPSULES >> CAPSULES TEMOZOLOMIDE TEMOSIDE 20 CAPSULES TEMOZOLOMIDE 20 MGCAPSULES PACK SIZE 1 X 5S ; MG CAPSULES PACK | India | Algeria | 2520 | |||
30049049 | TABLETS >> TABLETS CAPECITABINE CAPEGARD 500 TABLETS CAPECITABINE 500MG 19080 PACK X1X10S 190800 NOS ; 500MG | India | Algeria | 190800 | |||
30049049 | RODTEP >> RODTEPSCHEME RODTEP WE INTEND TO CLAIM BENEFIT UNDER RoDTEPSCHEME. ; RoDTEP SCHEME. 30049049 HSN Code | India | Algeria | 0.00 | |||
30049049 | TIME >> I-we undertake to abide by provisions offoreign Exchange Management act.1999 as amended from time to time including rea ; of foreign 30049049HSN Code | India | Algeria | 0.00 | |||
30049049 | RODTEP >> WE INTEND TO CLAIM BENEFIT UNDER RODTEP 30049049 HSN Code | India | Algeria | 0.00 | |||
30049049 | INJECTION >> PHARMA:MEGVAL-50MG INJECTION WITH DILUETN MELPHALAN IP 50 MG 1 VIAL INV.NO.:EOU-20-21-03-419 DT.30.03.2021 ; DILUET N MELPHALAN ; INV.NO.:EO U-20-21-03-419 HS 30049049 | India | Algeria | 964 | |||
30049049 | PHARMA >> PHARMA SAMPLE PHARMA SAMPLE HAVING N.C.V.:MEGVAL INJEC | India | Algeria | 2 | |||
30049049 | INJECTION >> RITUXIMAB INJECTION REDDITUX INJ 500MG RITUXIMAB INJECTION Q | India | Algeria | 1 | |||
30049049 | ABIDE >> I-WE UNDERTAKE TO ABIDE BY PROVISIONS OF | India | Algeria | 0.00 | |||
30049049 | ABIDE >> I-WE UNDERTAKE TO ABIDE BY PROVISIONS OF | India | Algeria | 0.00 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE | India | Algeria | 35400 | |||
30049049 | RODTE >> "WE INTEND TO CLAIM BENEFIT UNDER RoDTE | India | Algeria | 0.00 | |||
30049049 | CAPSULES >> CAPSULES TEMOZOLOMIDE TEMOSIDE 100 CAPSULES TEMOZOLOMIDE 100M | India | Algeria | 33300 | |||
30049049 | INJECTION >> PHARMA:MEGVAL 50MG INJECTION WITH DILUENT MELPHALAN IP 50 MG -1 VIAL INV. NO.: EOU-21-22-06-052 DT. 09.06.2021 ; DILUEN T ; N O.: | India | Algeria | 2 | |||
30049049 | INJECTION >> TRIOXIDE INJECTION ARSITRIARSENIC TRIOXIDE INJECTION 10MG-10ML "SAMPLE FOR ANALYSIS" ; 10MG-1 0ML | India | Algeria | 2 | |||
30049049 | VIAL >> SINGLE VIAL ALKACEL EACH INJ CONTAINS MELPHALAN 50MGEACH PACK CONTAINS SINGLE VIAL BATCH NOMPI2103AC M-D03-2021 E-D02-2024 ; 50MG EACH ; NO MPI2103AC | India | Algeria | 7 | |||
30049049 | INJECTION >> ALKACEL EACH INJECTION CONTAINS MELPHALAN 50MG EACH PACK CONTAINS SINGLE VIAL BATCH NOMPI2103AC M-D03-2021 E-D02-2024 ; MELPHALA N ; BA TCH | India | Algeria | 7 | |||
30049049 | INJECTION >> PHARMA:MEGVAL 50MG INJECTION WITH DILUEN | India | Algeria | 2 | |||
30049049 | INJECTION >> ALKACEL EACH INJECTION CONTAINS MELPHALAN 50MG EACH PACK CONTAINS SINGLE VIAL BATCH NOMPI2103AC M-D03-2021 E-D02-2024 ; MELPHALA N ; BA TCH | India | Algeria | 8 | |||
30049049 | PHARMA >> PHARMA SAMPLE PHARMA SAMPLE HAVING N.C.V. : MEGVAL INJ | India | Algeria | 2 | |||
30049049 | INJECTION >> PEMGEM 500 INJECTION 1VIAL ALGERIA | India | Algeria | 245 | |||
30049049 | INJECTION >> INJECTION MELPHALAN PHARMA:MEGVAL INJECTION MELPHALAN HYDRO | India | Algeria | 200 | |||
30049049 | TABS >> TABS IMATINIB IMALEK 400 TABS IMATINIB MESYLATE TABLE | India | Algeria | 5266 | |||
30049049 | RODTE >> We Intend to claim benefit under RoDTE | India | Algeria | 0.00 | |||
30049049 | CAPSULES >> IMATIB CAPSULES IMATIB CAPSULES 100MG IMATINIB MESYLATE | India | Algeria | 151680 | |||
30049049 | ABIDE >> 1 I- We undertake to abide by the provis | India | Algeria | 0.00 | |||
30049049 | BEVACIZUMAB 400MG/16MLQTY:02 VIALSFOR | India | Algeria | 2 | |||
30049049 | BEVACIZUMAB 100MG/4MLQTY:02 VIALSFOR | India | Algeria | 2 | |||
30049049 | XYLATIN 100 OXALIPLATIN INJECTION 100 MG | India | Algeria | 2000 | |||
30049049 | XYLATIN 50 OXALIPLATIN INJECTION 50 MG | India | Algeria | 14000 | |||
30049049 | XYLATIN 100 OXALIPLATIN INJECTION 100 MG | India | Algeria | 20 | |||
30049049 | XYLATIN 50 OXALIPLATIN INJECTION 50 MG | India | Algeria | 6400 | |||
30049049 | XYLATIN 50 OXALIPLATIN INJECTION 50 MG | India | Algeria | 20 | |||
30049049 | VESIMYCIN 10 MITOMYCIN FOR INJECTION USP 10MG 7440 VIALS | India | Algeria | 7440 | |||
30049049 | VESIMYCIN 10 MITOMYCIN FOR INJECTION USP 10MG 14963 VIALS | India | Algeria | 14963 | |||
30049049 | CAPEGARD 500TAB 10'S 23544 PACK X10'S=235440NOS REPLACEMENT OF GO ARTICLE / ODS / PRODUCT / ITEM NO COMMERCIAL VALUE FOR CUSTOM PURPOSE | India | Algeria | 235440 | |||
30049049 | APPLIED ONLINE FOR LUTARN NO:AD2703220205985 DT.08/03/2022 VALID UP TO :31.03.2023 | India | Algeria | 0.00 | |||
30049049 | XYLATIN 50 OXALIPLATIN INJECTION 50 MG | India | Algeria | 6400 | |||
30049049 | XYLATIN 100 OXALIPLATIN INJECTION 100 MG | India | Algeria | 20 | |||
30049049 | XYLATIN 50 OXALIPLATIN INJECTION 50 MG | India | Algeria | 20 | |||
30049049 | MSN PHARMACEUTICALS PRODUCT NAME: DARUNAVIR 800 MG TABLETS | India | Algeria | 30 | |||
30049049 | ZYGEM 1G INJECTION | India | Algeria | 30034 | |||
30049049 | DECITABINE FOR INJECTION 50MG/VIALINN: | India | Algeria | 1 | |||
30049049 | TEPAKIN 100MG INN: THIOTEPA POWDER FOR | India | Algeria | 1 | |||
30049049 | ERANFU 250MG/5ML INJ 2'S PFS ALGERIA | India | Algeria | 1665 | |||
30049049 | ERANFU 250MG/5ML INJ 2'S PFS ALGERIA | India | Algeria | 3219 | |||
30049049 | LENANGIO 10MGCAPSULE | India | Algeria | 407 | |||
30049049 | BACAZIRED60MG/1.5ML LNJCOMBIPACK ALGERIA | India | Algeria | 6490 | |||
30049049 | PHARMA : MEGVAL INJECTION MELPHALAN HYD | India | Algeria | 462 | |||
30049049 | PHARMA SAMPLE HAVING N.C.V. : MEGVAL INJ | India | Algeria | 2 | |||
30049049 | RITUXIMAB SOL P /PERF 100MG/10MLRITUXIM | India | Algeria | 860 | |||
30049049 | RITUXIMAB SOL P /PERF 100MG/10MLRITUXIM | India | Algeria | 3571 | |||
30049049 | RITUXIMAB SOL P /PERF 500MG/50MLRITUXIM | India | Algeria | 4528 | |||
30049049 | RITUXIMAB SOL P /PERF 100MG/10MLRITUXIM | India | Algeria | 3569 | |||
30049049 | RITUXIMAB SOL P /PERF 500MG/50MLRITUXIM | India | Algeria | 1372 | |||
30049049 | TEPAKIN 100 THIOTEPA FOR INJECTION USP | India | Algeria | 50 | |||
30049049 | PALBOCICLIB CAPSULES 125MG | India | Algeria | 2 | |||
30049049 | PALBOCICLIB CAPSULES 75MG | India | Algeria | 2 | |||
30049049 | PALBOCICLIB CAPSULES 100MG | India | Algeria | 2 | |||
30049049 | INJ >> MEGVAL INJ PHARMA SAMPLE HAVING N.C.V. : MEGVAL INJ | India | Algeria | 4 | |||
30049049 | INJECTION >> INJECTION MELPHALAN PHARMA : MEGVAL INJECTION MELPHALAN HYD | India | Algeria | 72 | |||
30049049 | IMATINIB >> IMATINIB MESYLATE IMALEK 400 TABS IMATINIB MESYLATE TABLE | India | Algeria | 5040 | |||
30049049 | REDDITUX >> RITUXIMAB REDDITUX RITUXIMAB REDDITUX INJ 500MG B/01 AMP R | India | Algeria | 15 | |||
30049049 | REDDITUX >> RITUXIMAB REDDITUX RITUXIMAB REDDITUX INJ 100MG B/01 RITUX | India | Algeria | 15 | |||
30049049 | IRINOTECAN >> IRINOTECAN TAX DOCUMENT NO:KLS/EXP/22/21-22 | India | Algeria | 0.15 | |||
30049049 | VIAL >> METHOTEX EACH VIAL OF METHOTREXATE 500 | India | Algeria | 24 | |||
30049049 | TABS >> TABS IMATINIB IMALEK 400 TABS IMATINIB MESYLATE TABLE | India | Algeria | 33653 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE | India | Algeria | 33600 | |||
30049049 | 2 Any claim made in this shipping bill o | India | Algeria | 0.00 | |||
30049049 | REGARD >> I-We , in regard to my-our claim under R | India | Algeria | 0.00 | |||
30049049 | TIME >> audit in the manner and for the time per | India | Algeria | 0.00 | |||
30049049 | RODTEP >> under RoDTEP scheme , and relevant notifi | India | Algeria | 0.00 | |||
30049049 | ABIDE >> I-we undertake to abide by provisions of | India | Algeria | 0.00 | |||
30049049 | ABIDE >> 1 I- We undertake to abide by the provis | India | Algeria | 0.00 |
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
30049049 | INJECTION >> TRIOXIDE INJECTION ARSITRI ARSENIC TRIOXIDE INJECTION 10MG-10ML B.NO:113206 MANUFACTURING .DT:02-2019; EXP.DT.01-2021 ; 10MG -10ML B.NO:113206 ; EXP.DT .01-2021 | India | Algeria | 403 | |||
30049049 | MEDICAMENTS >> MEDICAMENTS EXCLUDING *" MEDICAMENTSEXCLUDING GOODS OF HEADING 3002,3005 OR 3006 CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSESINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS OR IN FORMS OR PACKINGS FOR | India | Algeria | 1 | |||
30049049 | TABS >> TABS IMATINIB IMALEK 400 TABS IMATINIB MESYLATE TABLE | India | Algeria | 3276 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE ALPHA FORM 400MG PACK SIZE3X10S ; MESYLATE ALPHA | India | Algeria | 2745 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMALEK 100MG TABLETS IMATINIB MESYLATE | India | Algeria | 18519 | 60 More Columns Available | ||
30049049 | TABLETS >> MESYLATE TABLETS IMALEK 400 TABS IMATINIB MESYLATE TABLETS 400 MG PACK: 6S STRIP OTHER EACH FILM-COATED TABS CONTNS: IMATINIB MESY ; TABLE TS ; EAC H | India | Algeria | 4739 | |||
30049049 | MEDICAMENTS >> MEDICAMENTS EXCLUDING *" MEDICAMENTSEXCLUDING GOODS OF HEADING 3002,3005 OR 3006 CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSESINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS OR IN FORMS OR PACKINGS FOR | India | Algeria | 1 | |||
30049049 | DOCUMENT >> TAX DOCUMENT NO1301403031 DT16.08.2019 " AP PLIED ONLINE FOR LUT - ARN - AD270319006 825X "DT 22-03-2019 VALID UPTO DT31.0 | India | Algeria | 0.00 | |||
30049049 | DOCUMENT >> TAX DOCUMENT NO: 1301402369 DT: 27.06.2019 APPLIED ONLINE FOR LUT ARN NO.AD270319006825X VALID UPTO.31.03.2020 ; 27.06.2019 APPLIED ; NO.AD2703190 06825X | India | Algeria | 0.00 | |||
30049049 | TABLETS >> TABLETS CAPECIINE CAPEGARD 500MG TABLETS CAPECIINE 500MGTABLETS 1X10'S-PACK ; 500MG TABLETS | India | Algeria | 179960 | |||
30049049 | " APPLIED ONLINE FOR LUT - ARN - AD27032 | India | Algeria | 0.00 | |||
30049049 | TABLETS >> TABLETS CAPECITABINE CAPEGARD 500 TABLETS CAPECITABINE 500MG 1 X 10S-NOS ; 500MG | India | Algeria | 130460 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE | India | Algeria | 3600 | |||
30049049 | TIME >> I-WE UNDERTAKE TO ABIDE BY PROVISIONS OFFOREIGN EXCHANGE MANAGEMENT ACT 1999 AS AMENDED FROM TIME TO TIME INCLUDING ; OF FOREIGN | India | Algeria | 0.00 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE | India | Algeria | 37350 | |||
30049049 | MEDICAMENTS >> MEDICAMENTS EXCLUDING " MEDICAMENTSEXCLUDING GOODS OF HEADING 3002,3005 OR 3006 CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSESINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS OR IN FORMS OR PACKINGS FOR | India | Algeria | 0.00 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE ALPHA FORM 400MG 1200 PACK X3X10S=36000 NOS ; MESYLATE ALPHA ; X3X10S=3 6000 | India | Algeria | 36000 | |||
30049049 | FREE >> FREE SAMPLE FREE SAMPLE OF NCV: HODPRO PROCARBAZINE | India | Algeria | 100 | |||
30049049 | CAPS >> HYDROCHLORIDE CAPS HODPRO PROCARBAZINE HYDROCHLORIDE CAPS U | India | Algeria | 12400 | |||
30049049 | APPLIED ONLINE FOR LUT ARN AD27032001168 | India | Algeria | 0.01 | |||
30049049 | CAPSULES >> CAPSULES TEMOZOLOMIDE TEMOSIDE 20 CAPSULES TEMOZOLOMIDE 20 MGCAPSULES PACK SIZE 1 X 5S ; MG CAPSULES PACK | India | Algeria | 2520 | |||
30049049 | TABLETS >> TABLETS CAPECITABINE CAPEGARD 500 TABLETS CAPECITABINE 500MG 19080 PACK X1X10S 190800 NOS ; 500MG | India | Algeria | 190800 | |||
30049049 | RODTEP >> RODTEPSCHEME RODTEP WE INTEND TO CLAIM BENEFIT UNDER RoDTEPSCHEME. ; RoDTEP SCHEME. 30049049 HSN Code | India | Algeria | 0.00 | |||
30049049 | TIME >> I-we undertake to abide by provisions offoreign Exchange Management act.1999 as amended from time to time including rea ; of foreign 30049049HSN Code | India | Algeria | 0.00 | |||
30049049 | RODTEP >> WE INTEND TO CLAIM BENEFIT UNDER RODTEP 30049049 HSN Code | India | Algeria | 0.00 | |||
30049049 | INJECTION >> PHARMA:MEGVAL-50MG INJECTION WITH DILUETN MELPHALAN IP 50 MG 1 VIAL INV.NO.:EOU-20-21-03-419 DT.30.03.2021 ; DILUET N MELPHALAN ; INV.NO.:EO U-20-21-03-419 HS 30049049 | India | Algeria | 964 | |||
30049049 | PHARMA >> PHARMA SAMPLE PHARMA SAMPLE HAVING N.C.V.:MEGVAL INJEC | India | Algeria | 2 | |||
30049049 | INJECTION >> RITUXIMAB INJECTION REDDITUX INJ 500MG RITUXIMAB INJECTION Q | India | Algeria | 1 | |||
30049049 | ABIDE >> I-WE UNDERTAKE TO ABIDE BY PROVISIONS OF | India | Algeria | 0.00 | |||
30049049 | ABIDE >> I-WE UNDERTAKE TO ABIDE BY PROVISIONS OF | India | Algeria | 0.00 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE | India | Algeria | 35400 | |||
30049049 | RODTE >> "WE INTEND TO CLAIM BENEFIT UNDER RoDTE | India | Algeria | 0.00 | |||
30049049 | CAPSULES >> CAPSULES TEMOZOLOMIDE TEMOSIDE 100 CAPSULES TEMOZOLOMIDE 100M | India | Algeria | 33300 | |||
30049049 | INJECTION >> PHARMA:MEGVAL 50MG INJECTION WITH DILUENT MELPHALAN IP 50 MG -1 VIAL INV. NO.: EOU-21-22-06-052 DT. 09.06.2021 ; DILUEN T ; N O.: | India | Algeria | 2 | |||
30049049 | INJECTION >> TRIOXIDE INJECTION ARSITRIARSENIC TRIOXIDE INJECTION 10MG-10ML "SAMPLE FOR ANALYSIS" ; 10MG-1 0ML | India | Algeria | 2 | |||
30049049 | VIAL >> SINGLE VIAL ALKACEL EACH INJ CONTAINS MELPHALAN 50MGEACH PACK CONTAINS SINGLE VIAL BATCH NOMPI2103AC M-D03-2021 E-D02-2024 ; 50MG EACH ; NO MPI2103AC | India | Algeria | 7 | |||
30049049 | INJECTION >> ALKACEL EACH INJECTION CONTAINS MELPHALAN 50MG EACH PACK CONTAINS SINGLE VIAL BATCH NOMPI2103AC M-D03-2021 E-D02-2024 ; MELPHALA N ; BA TCH | India | Algeria | 7 | |||
30049049 | INJECTION >> PHARMA:MEGVAL 50MG INJECTION WITH DILUEN | India | Algeria | 2 | |||
30049049 | INJECTION >> ALKACEL EACH INJECTION CONTAINS MELPHALAN 50MG EACH PACK CONTAINS SINGLE VIAL BATCH NOMPI2103AC M-D03-2021 E-D02-2024 ; MELPHALA N ; BA TCH | India | Algeria | 8 | |||
30049049 | PHARMA >> PHARMA SAMPLE PHARMA SAMPLE HAVING N.C.V. : MEGVAL INJ | India | Algeria | 2 | |||
30049049 | INJECTION >> PEMGEM 500 INJECTION 1VIAL ALGERIA | India | Algeria | 245 | |||
30049049 | INJECTION >> INJECTION MELPHALAN PHARMA:MEGVAL INJECTION MELPHALAN HYDRO | India | Algeria | 200 | |||
30049049 | TABS >> TABS IMATINIB IMALEK 400 TABS IMATINIB MESYLATE TABLE | India | Algeria | 5266 | |||
30049049 | RODTE >> We Intend to claim benefit under RoDTE | India | Algeria | 0.00 | |||
30049049 | CAPSULES >> IMATIB CAPSULES IMATIB CAPSULES 100MG IMATINIB MESYLATE | India | Algeria | 151680 | |||
30049049 | ABIDE >> 1 I- We undertake to abide by the provis | India | Algeria | 0.00 | |||
30049049 | BEVACIZUMAB 400MG/16MLQTY:02 VIALSFOR | India | Algeria | 2 | |||
30049049 | BEVACIZUMAB 100MG/4MLQTY:02 VIALSFOR | India | Algeria | 2 | |||
30049049 | XYLATIN 100 OXALIPLATIN INJECTION 100 MG | India | Algeria | 2000 | |||
30049049 | XYLATIN 50 OXALIPLATIN INJECTION 50 MG | India | Algeria | 14000 | |||
30049049 | XYLATIN 100 OXALIPLATIN INJECTION 100 MG | India | Algeria | 20 | |||
30049049 | XYLATIN 50 OXALIPLATIN INJECTION 50 MG | India | Algeria | 6400 | |||
30049049 | XYLATIN 50 OXALIPLATIN INJECTION 50 MG | India | Algeria | 20 | |||
30049049 | VESIMYCIN 10 MITOMYCIN FOR INJECTION USP 10MG 7440 VIALS | India | Algeria | 7440 | |||
30049049 | VESIMYCIN 10 MITOMYCIN FOR INJECTION USP 10MG 14963 VIALS | India | Algeria | 14963 | |||
30049049 | CAPEGARD 500TAB 10'S 23544 PACK X10'S=235440NOS REPLACEMENT OF GO ARTICLE / ODS / PRODUCT / ITEM NO COMMERCIAL VALUE FOR CUSTOM PURPOSE | India | Algeria | 235440 | |||
30049049 | APPLIED ONLINE FOR LUTARN NO:AD2703220205985 DT.08/03/2022 VALID UP TO :31.03.2023 | India | Algeria | 0.00 | |||
30049049 | XYLATIN 50 OXALIPLATIN INJECTION 50 MG | India | Algeria | 6400 | |||
30049049 | XYLATIN 100 OXALIPLATIN INJECTION 100 MG | India | Algeria | 20 | |||
30049049 | XYLATIN 50 OXALIPLATIN INJECTION 50 MG | India | Algeria | 20 | |||
30049049 | MSN PHARMACEUTICALS PRODUCT NAME: DARUNAVIR 800 MG TABLETS | India | Algeria | 30 | |||
30049049 | ZYGEM 1G INJECTION | India | Algeria | 30034 | |||
30049049 | DECITABINE FOR INJECTION 50MG/VIALINN: | India | Algeria | 1 | |||
30049049 | TEPAKIN 100MG INN: THIOTEPA POWDER FOR | India | Algeria | 1 | |||
30049049 | ERANFU 250MG/5ML INJ 2'S PFS ALGERIA | India | Algeria | 1665 | |||
30049049 | ERANFU 250MG/5ML INJ 2'S PFS ALGERIA | India | Algeria | 3219 | |||
30049049 | LENANGIO 10MGCAPSULE | India | Algeria | 407 | |||
30049049 | BACAZIRED60MG/1.5ML LNJCOMBIPACK ALGERIA | India | Algeria | 6490 | |||
30049049 | PHARMA : MEGVAL INJECTION MELPHALAN HYD | India | Algeria | 462 | |||
30049049 | PHARMA SAMPLE HAVING N.C.V. : MEGVAL INJ | India | Algeria | 2 | |||
30049049 | RITUXIMAB SOL P /PERF 100MG/10MLRITUXIM | India | Algeria | 860 | |||
30049049 | RITUXIMAB SOL P /PERF 100MG/10MLRITUXIM | India | Algeria | 3571 | |||
30049049 | RITUXIMAB SOL P /PERF 500MG/50MLRITUXIM | India | Algeria | 4528 | |||
30049049 | RITUXIMAB SOL P /PERF 100MG/10MLRITUXIM | India | Algeria | 3569 | |||
30049049 | RITUXIMAB SOL P /PERF 500MG/50MLRITUXIM | India | Algeria | 1372 | |||
30049049 | TEPAKIN 100 THIOTEPA FOR INJECTION USP | India | Algeria | 50 | |||
30049049 | PALBOCICLIB CAPSULES 125MG | India | Algeria | 2 | |||
30049049 | PALBOCICLIB CAPSULES 75MG | India | Algeria | 2 | |||
30049049 | PALBOCICLIB CAPSULES 100MG | India | Algeria | 2 | |||
30049049 | INJ >> MEGVAL INJ PHARMA SAMPLE HAVING N.C.V. : MEGVAL INJ | India | Algeria | 4 | |||
30049049 | INJECTION >> INJECTION MELPHALAN PHARMA : MEGVAL INJECTION MELPHALAN HYD | India | Algeria | 72 | |||
30049049 | IMATINIB >> IMATINIB MESYLATE IMALEK 400 TABS IMATINIB MESYLATE TABLE | India | Algeria | 5040 | |||
30049049 | REDDITUX >> RITUXIMAB REDDITUX RITUXIMAB REDDITUX INJ 500MG B/01 AMP R | India | Algeria | 15 | |||
30049049 | REDDITUX >> RITUXIMAB REDDITUX RITUXIMAB REDDITUX INJ 100MG B/01 RITUX | India | Algeria | 15 | |||
30049049 | IRINOTECAN >> IRINOTECAN TAX DOCUMENT NO:KLS/EXP/22/21-22 | India | Algeria | 0.15 | |||
30049049 | VIAL >> METHOTEX EACH VIAL OF METHOTREXATE 500 | India | Algeria | 24 | |||
30049049 | TABS >> TABS IMATINIB IMALEK 400 TABS IMATINIB MESYLATE TABLE | India | Algeria | 33653 | |||
30049049 | TABLETS >> TABLETS IMATINIB IMATIB 400MG TABLETS IMATINIB MESYLATE | India | Algeria | 33600 | |||
30049049 | 2 Any claim made in this shipping bill o | India | Algeria | 0.00 | |||
30049049 | REGARD >> I-We , in regard to my-our claim under R | India | Algeria | 0.00 | |||
30049049 | TIME >> audit in the manner and for the time per | India | Algeria | 0.00 | |||
30049049 | RODTEP >> under RoDTEP scheme , and relevant notifi | India | Algeria | 0.00 | |||
30049049 | ABIDE >> I-we undertake to abide by provisions of | India | Algeria | 0.00 | |||
30049049 | ABIDE >> 1 I- We undertake to abide by the provis | India | Algeria | 0.00 |
Volza's data of India HSN Code 30049049 exports allows you to study detailed data with buyer supplier names for last 10 years.
Volza's data of India HSN Code 30049049 exports helps you create a export strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
You can find India HSN Code 30049049 export market intelligence of last 10 years with buyer, supplier, price and volume from volza.com
You can find New markets for HSN Code 30049049 exports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
Top 1 HSN codes for HSN Code 30049049 are HSN Code 30049049 , You can check for details at https://www.volza.com/hs-codes.
Volza's data of India HSN Code 30049049 exports to Algeria is 100% authentic as it is based on actual export import shipments and is collected globally from over 20,000 ports from over 70+ Countries.
Data of India HSN Code 30049049 exports to Algeria contains strategic information and is very useful for exporters and importers who want to expand global trade, improve supply chain of HSN Code 30049049, find economical vendors, new buyers and fast growing markets.
Data of India HSN Code 30049049 exports to Algeria contains date of shipment, Name and contact details of exporter, importer, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
We update information of India HSN Code 30049049 exports to Algeria every month.
As per the Volza's India export data of HSN Code 30049049, Algeria accounted for maximum share with 575 shipments.
India wide 575 of HSN Code 30049049 shipments were exported to Algeria.
You can download latest data of Jan-2024 of India HSN Code 30049049 exports to Algeria here
You can download Volza India HSN Code 30049049 export data with names of buyers and suppliers.
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
Online |
---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
View More |
Volza Consulting |
---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
View More |
Support
Important Links
Partners
Trade Data
About Us
Partners